Tjalma syndrome (pseudo-pseudo Meigs') as initial manifestation of juvenile-onset systemic lupus erythematosus

Reumatol Clin (Engl Ed). 2019 Sep-Oct;15(5):e41-e43. doi: 10.1016/j.reuma.2017.04.003. Epub 2017 May 15.
[Article in English, Spanish]

Abstract

Tjalma syndrome or pseudo-pseudo Meigs' syndrome is a clinical condition characterized by pleural effusion, ascites and elevated CA-125 with no associated benign or malignant ovarian tumor in a patient with systemic lupus erythematosus (SLE). Tjalma described the first case of a patient with SLE, pleural effusion, ascites and elevated CA-125. We report the first case in a 14-year old patient who presented with ascites and pleural effusion refractory to treatment and elevated CA-125, in the absence of an ovarian tumor, that warranted aggressive management.

Keywords: CA-125; Lupus eritematoso sistémico; Pseudo-pseudo Meigs; Pseudo-pseudo Meigs’; Systemic lupus erythematosus; Síndrome de Tjalma; Tjalma syndrome.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acute Kidney Injury
  • Adolescent
  • Ascites / therapy
  • CA-125 Antigen / blood
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / complications*
  • Meigs Syndrome / diagnosis
  • Meigs Syndrome / drug therapy
  • Meigs Syndrome / etiology*
  • Paracentesis
  • Pleural Effusion / etiology
  • Purpura, Thrombotic Thrombocytopenic / therapy
  • Rituximab / therapeutic use

Substances

  • CA-125 Antigen
  • Rituximab
  • Cyclophosphamide